Tweet
After de novo assembly using Trinity, how to calculate coverage??
-
Last edited by ankitarathore; 05-21-2013, 12:31 AM. -
Hi, I want to run a de novo with trinity. Which command should I use to start? I have single reads in fq
thanks -
You should check http://trinityrnaseq.sourceforge.net/ for details.
But something like the following should get you running:
Trinity --seqType fq --JM 100G --single reads.fq --CPU 6
Check your available RAM memory and number of cores to assign correctly the JM and CPU parameters. Substitute "reads.fq" for your read file.Comment
-
If RAM is 1GB then what to do?Comment
-
Not much (at least not in terms of de novo assembly). Unless the genome you are working on is the size of a small bacteriopahge.Originally posted by Nanu View PostComment
-
Genomax,
I executed the fastqc , fastx and indexing the reference genome through Bowtie. When i executing the tophat2..it created the accepted.bam and unmapped.bam, align-summary.txt, logs etc...
Here I got only 1 KB size of accepted hits..while unmapped.bam is 200MB in size. i have heterologous reference genome. I downloaded the genome from Ensembl database. I have to find the novel gene, its expression.
Is any particular pipeline for roche transcriptome data?
I am trying to evaluate as denovo through trinity for roche transcriptome data analysis. here increased the RAM as 6GB.
Please help me..Comment
-
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM -
Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.07-01-2026, 11:43 AM
Comment